18
Participants
Start Date
October 31, 2002
Primary Completion Date
October 31, 2007
Study Completion Date
January 31, 2008
Etanercept
The study drug was provided in lyophilized 10 mg vials to be reconstituted with 1 ml of diluent/vial and was administered at a dose of 0.4 mg/Kg up to maximum dose of 25 mg/dose SC twice weekly
Placebo
administered at 0.4 mg/Kg/dose SC up to 25 mg max twice weekly
Collaborators (1)
Amgen
INDUSTRY
State University of New York at Buffalo
OTHER